Article
Blood acylcarnitine levels in normal newborns and heterozygotes for medium-chain acyl-CoA dehydrogenase deficiency: a relationship between genotype and biochemical phenotype?
Journal of inherited metabolic disease - 1 Jan 2004
Lehotay D C, LePage J, Thompson J R, Rockman-Greenberg C
Abstract excerpt
Patients with medium-chain acyl-CoA dehydrogenase (MCAD) deficiency are unable to metabolize medium-chain fatty acids. Affected patients display a characteristic acylcarnitine profile when blood spots are collected after birth and analysed by tandem mass spectrometry. To determine the potential r...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
